SWOG S2107: Randomized Phase II Trial of Encorafenib and Cetuximab with or Without Nivolumab for Patients with Previously Treated, Microsatellite Stable, BRAFV600E Metastatic And/or Unresectable Colorectal Cancer.
Journal of Clinical Oncology（2024）
Key words
283-237-255,261-265,261-374,3282-646-2680,14,2827,126,14,2827,126,38092-18849,38092-18849,38092-22188
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined